Information Provided By: 
Fly News Breaks for March 1, 2017
EVHC
Mar 1, 2017 | 07:27 EDT
Jefferies analyst Brian Tanquilut believes Envision Healthcare's discounted valuation shows that investors have been anticipating a volume-driven FY17 guidance miss for the last few months. Thus, last night's guidance shortfall, while wider than expectations, does not come as a surprise, Tanquilut tells investors in a post-earnings research note. The analyst lowered his price target for Envision shares to $82 from $90 and keeps a Buy rating on the name. He believes the company's fundamentals are intact and the valuation is "compelling."
News For EVHC From the Last 2 Days
There are no results for your query EVHC
